Pre-exposure Prophylaxis

Active Resources: 34

Fact Sheets

Patient Information

Coinfection Guidelines (Hep, TB, STIs)

Web Links

Articles: 4

  • HIV Meds Update: PrEP Uptake by Sex, Race, and Age

    At the ASM Microbe meeting in June, researchers from Gilead Sciences presented data on use of TDF/FTC (Truvada) PrEP in the United States according to sex and race. They evaluated national pharmacy databases to identify prescriptions of TDF/FTC given for PrEP between January 2012 and September...

  • PrEP: Bone Density Improves after Stopping TDF/FTC

    Tenofovir disoproxil fumarate (TDF) may cause decreases in bone mineral density (BMD) both in HIV-infected patients treated with TDF-containing ARV regimens and in HIV-uninfected persons who use it for PrEP. A substudy of the large iPrEx trial of TDF/FTC PrEP in MSM and transgender...

  • Tissue Levels of TAF: Too Low for PrEP?

    A pharmacokinetic study presented at the Conference on Retroviruses and Opportunistic Infections in Boston in February evaluated concentrations of tenofovir (TFV) and TFV-diphosphate (DP) in genital and rectal tissue and in anogenital fluid samples after administration of oral tenofovir...

  • Listening in on the Warmline, PEPline and the Perinatal HIV Hotline: Consultation when Considering PrEP

    Pre-exposure prophylaxis (PrEP), specifically the daily use of oral antiretroviral drugs as an HIV prevention measure, has been an increasingly hot topic in the HIV world since studies emerged in 2010 showing promising transmission prevention results among medication-adherent men who have sex...

Day Title
8/22
Back to School: Epidemiology and Risk Among College Students
Event type: Webinars
9/6
U.S. Conference on AIDS (USCA)
9/19
2018 Eastern Region HIV/AIDS Fall Summit
9/21
Advancing Excellence in Transgender Health: A Core Course for the Whole Care Team
9/25
Women and PrEP Symposium
10/3
The Fundamentals of Prevention Counseling
10/15
HIV Medical Management: Clinical and Didactic Experience for Providers
11/15
National Rural Health Day
Event type: Awareness Days
12/3
2018 Biomedical HIV Prevention Summit (The Summit)
Day Title
8/18
ACRN/AACRN Review
3/4
CROI 2018: Boston